Chapters
Introduction
Optimal prevention
Use of new agents
Monitoring after prophylaxis or treatment
The management of low viral loads
Resistant disease
Use of immunoglobulins
Chapters
Speaker Panel
Camille N. Kotton MD, FIDSA, FAST
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases. Massachusetts General Hospital
Associate Professor, Harvard Medical School
Emily A. Blumberg MD
Professor of Medicine, Director
Transplant Infectious Diseases,
Perelman School of Medicine, University
of Pennsylvania
Michael D. Green MD, MPH
UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine
Yoichiro Natori MD, MPH
Miami Transplant Institute, University
of Miami
Deborah J. Levine MD FAST FCCP
Professor of Medicine
Division of Pulmonary and Critical Care and Allergy.
Stanford University
